Fresenius Medical Care introduces 2008K@home(TM) hemodialysis delivery system in North America
series hemodialysis machine platform that has delivered superior hemodialysis therapy for over 30 years. This machine combines safety, efficacy and reliability with a simple user-interface that incorporates an on-screen tutorial to walk the user through set-up, treatment, and disconnection from therapy. Earlier this year, the U.S. Food and Drug Administration (FDA) cleared the 2008K@home machine for use.
"With the growing interest in home therapies in the U.S., the 2008K@home machine provides another option for delivering hemodialysis to patients who want the freedom associated with being at home," said Maureen Lyden-Green, Vice President for Home Therapies at Fresenius Medical Care North America. "The 2008K@home provides patients with a smaller version of the in-center machine and allows flexibility to deliver a customized physician's dialysis prescription for each Fresenius Medical Care AG & Co. KGaA, Corporate Communications, 61346 Bad Homburg Page 2 of 2 patient, meeting the patient's medical needs and suiting their lifestyle," continued Chief Medical and Regulatory Affairs Officer Dr. Jose Diaz-Buxo.
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2 million individuals worldwide. Through its network of 2,874 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 228,239 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products.
For more information about Fresenius Medical Care, visit the Company's website at www.fmcag.com.
Press releases you might also be interested in
Weitere Informationen zum Thema "Medizintechnik":
ARM und NVIDIA entwickeln gemeinsam KI-Chips
Um die Entwicklung des eigenen KI-Projekts Trillium voranzutreiben, hat Prozessorentwickler ARM eine Partnerschaft mit dem GPU-Hersteller NVIDIA geschlossen. Dessen Deep-Learning-Architektur NVDLA wird fortan in die Trillium-Plattform integriert.Weiterlesen